Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Biosensors
      • Chromatography
      • Flow Cytometry
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
LC–MS strategies for advanced modalities: ADC, AOC, multidomain and RNA therapeutics 2 days 6 hours 15 mins 42 secs REGISTER NOW

Video: APA 2015 – Reaching new heights in targeted quantitation with HRMS

15 Mar 2016
Written by Mark Wrona (Waters Corporation)
Chromatography MS (LC–MS/MS, HRMS, IMS)

https://www.youtube.com/watch?v=62i-2wAEAWgMark Wrona, Senior Science Manager at Waters Corporation, discusses the use of high resolution mass spectrometry (HRMS) for targeted quantitation studies. This presentation was originally given at APA 2015 in Boston (MA, USA).

Top content

  • eBook: Precision bioanalysis for every molecule
  • Global initiative seeks to fast-track personalized therapies for rare diseases
  • Editor’s highlights from NextGen Biomed 2026

Related tags

HRMS microfluidics
Previous article Next article

Related articles

8 JUN 2011 CHROMATOGRAPHY
Conference Report: Pittcon Conference and Expo 2011
20 FEB 2015 GENERAL INTEREST
Waters and Ferring collaborate to host Peptide Bioanalysis Forum
6 JUN 2012 COLLABORATIONS AND MERGERS
Conference Report: Bioanalytical sessions at the 2011 Eastern Analytical Symposium
13 NOV 2019 GENERAL INTEREST
A new king of quantitation?
31 AUG 2016 JOURNAL ARTICLES
HRMS using a Q-Exactive series mass spectrometer for regulated quantitative bioanalysis: how, when, and why to implement
24 MAR 2016 AUTOMATION
Validation of an integrated series of ligand-binding assays for the quantitative determination of antibody–drug conjugates in biological matrices
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility
  • Editorial Policies

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone